Projects per year
Personal profile
Research interests
Hemophilia
Sickle Cell Disease
Specialisation
Network
-
Mathôt R.A.A.: Population pharmacokinetic-pharmacodynamic research
Achterbergh, R., Berends, S. E., ten Berg - Lammers, L. A., Bijleveld, Y. A., Hodiamont, C. J., Preijers, T., Wind, C. M., Mathot, R. A. A., Fijnvandraat, K., de Haan, T. R., Kemper, M. M., Klümpen, H., van Hest, R. M., Kuks, P. F. M., Zwaan, C. M., Franken, L., Hazendonk, C., Masman, A., van Moort, I., Sassen, S., Schutte, L. M., Cnossen, M., van Gelder, T., Kruip, M. J. H. A., Leebeek, F. W. G. & Tibboel, D.
1/12/2012 → …
Project: Research
-
Fijnvandraat C.J.: Etiology of inhibitor development in hemophilia & Cerebral infarction and vaso-occlusion in Sickle Cell Disease
Fijnvandraat, K., Peters, M., Gouw, S. C., Bouva, M. J., Gunnink, S. F., Sins, J. W. R. W. R., Stokhuijzen, E. & Eckhardt, C.
1/12/2011 → …
Project: Research
-
Kuijpers T.W.: Infection and inflammation: on the crossroad of hematology and immunology
Aarts, C. E. M., de Back, D. Z., Barendregt, A. M., van Beek, A. E., de Blauw, D., Blokhuis, C., Bouva, M. J., Bruggeman, C. W., Bruning, A. H. L., Dalimot, J. J., Dietz, S. M., van de Geer, A., van Gulik, C. C., Gunnink, S. F., Keizer, S. M. P. D., Klaassen, I. L. M., Meinderts, S. M., Nagelkerke, S. Q., Pouw, R. B., van Rees, D. J., Scheenstra, M. R., Schonenberg, D., Schreurs, R. R. C. E., Sins, J. W. R. W. R., Stokhuijzen, E., Treffers, L. W., Tuijnenburg, P., Kuijpers, T., Boele van Hensbroek, M., Fijnvandraat, K., Pajkrt, D., van Rossum, M. A. J. & Hemke, R.
1/01/2006 → …
Project: Research
-
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Eckhardt, C. L., van Velzen, A. S., Peters, M., Astermark, J., Brons, P. P., Castaman, G., Cnossen, M. H., Dors, N., Escuriola-Ettingshausen, C., Hamulyak, K., Hart, D. P., Hay, C. R. M., Haya, S., van Heerde, W. L., Hermans, C., Holmström, M., Jimenez-Yuste, V., Keenan, R. D., Klamroth, R., Laros-van Gorkom, B. A. P., & 25 others , 2013, In: Blood. 122, 11, p. 1954-1962Research output: Contribution to journal › Article › Academic › peer-review
169 Citations (Scopus) -
Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A
Castaman, G. & Fijnvandraat, K., 2014, In: Blood. 124, 15, p. 2333-2336Research output: Contribution to journal › Article › Academic › peer-review
27 Citations (Scopus) -
Diagnosis and management of haemophilia
Fijnvandraat, K., Cnossen, M. H., Leebeek, F. W. G. & Peters, M., 2012, In: BMJ (Clinical research ed.). 344, p. e2707Research output: Contribution to journal › Review article › Academic › peer-review
77 Citations (Scopus) -
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors
AUTHOR GROUP, 2016, In: Thrombosis and haemostasis. 115, 3, p. 543-550Research output: Contribution to journal › Article › Academic › peer-review
23 Citations (Scopus) -
Inhibitor development and mortality in non-severe hemophilia A
AUTHOR GROUP, 2015, In: Journal of thrombosis and haemostasis. 13, 7, p. 1217-1225Research output: Contribution to journal › Article › Academic › peer-review
49 Citations (Scopus)